Mexico City – September 22, 2026 -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) has filed a Notice of Rights with the Bolsa Mexicana de Valores declaring a cash dividend of $0.20 Mexican pesos per common share, totaling $200,000,000.00 pesos based on shares currently outstanding.
Board authorizes 17th dividend under shareholder mandate
The payment marks the company's seventeenth dividend distribution and was approved by Genomma Lab's Board of Directors under powers delegated at the Annual General Shareholders Meeting held on April 24, 2025. The per-share amount is calculated against the total number of LABB shares outstanding on the Mexican Stock Exchange.
Company signals continued quarterly payout policy
Subject to the terms set by the AGSM, Genomma Lab confirmed its intention to maintain dividend distributions on a quarterly basis going forward. The pharmaceutical and personal care products company, listed on the BMV under ticker LABB and on Bloomberg as LABB:MM, operates across Latin America with a distribution network spanning premium branded consumer health products.